Being developed to reduce the risk of Endophthalmitis following ocular (cataract) surgery. Clinical Investigation Stage: Phase I.
Micro implant. Maximum infection protection.
The Target Product Profile for the Levofloxacin Ocular Implant, currently under development, aims to deliver the following clinical benefits:
Early clinical studies (NCT04682288) conducted by PolyActiva have met clinical trial objectives. The Levofloxacin Ocular implant has not been approved by the U.S. Food and Drug Administration (FDA)